619 filings
Page 9 of 31
424B5
0af97rrx
10 Mar 17
Prospectus supplement for primary offering
12:00am
8-K
ekiuicqp9m9lci8pw8tz
10 Mar 17
TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2016 Financial Results and Business Update
12:00am
8-K
dhcenh
9 Mar 17
Entry into a Material Definitive Agreement
12:00am
424B5
msify
8 Mar 17
Prospectus supplement for primary offering
12:00am
8-K
z6b5as4 p73awwnjv4
6 Mar 17
Other Events
12:00am
8-K
xrm3lungl0i46gq2xte
4 Jan 17
Departure of Directors or Certain Officers
12:00am
8-K
n2266or3fj g2
6 Dec 16
TG Therapeutics, Inc. Announces Double & Triple Combination Therapy Data Presentations at the 58th American Society of Hematology Annual Meeting
12:00am
8-K
yvyql1q3p tt0
5 Dec 16
TG Therapeutics, Inc. Announces Preclinical Data Presentations for TGR-1202 at the 58th American Society of Hematology Annual Meeting
12:00am
8-K
3nnvhbeyl 8k0ces76z
7 Nov 16
TG Therapeutics, Inc. Provides Business Update and Reports Third Quarter 2016 Financial Results
12:00am
8-K
gyed8nqwrf77i
13 Oct 16
TG Therapeutics, Inc. Amends the GENUINE Phase 3 Clinical Trial to Accelerate Study Completion by Revising Primary Endpoint to Overall Response Rate
12:00am
CT ORDER
0475 pep8zg0
4 Oct 16
Confidential treatment order
12:00am
8-K
kuwajy y7
8 Aug 16
TG Therapeutics, Inc. Announces Second Quarter 2016 Financial Results and Business Update
12:00am
8-K
vzxz 242b5406911
14 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
b4cj dnbmdfo9l0ni
6 Jun 16
Other Events
12:00am
8-K
wsbg0jtq0et20oe
2 Jun 16
Entry into a Material Definitive Agreement
12:00am